Table 1 Parameters used for UPF of schizophrenia treatment and their corresponding sources
Input | Value | Source | ||||
|---|---|---|---|---|---|---|
Demography | ||||||
Cohort size | 1,000,000 | Authors’ assumption | ||||
Cohort size per quintile | 200,000 | Authors’ assumption | ||||
Treatment impact | ||||||
a. Population-wide | ||||||
Coefficient of relative risk aversion | 3 | |||||
Disability weight (residual state) | 0.576 | [15] | ||||
Disability weight (acute state) | 0.756 | [15] | ||||
Treatment effectiveness (anti-psychotic medication + psychosocial treatment) | 24 % | [5] | ||||
Treatment adherence rate | 76 % | [19] | ||||
b. Quintile-specific | I | II | III | IV | V | |
Current coverage | 30 % | 35 % | 40 % | 45 % | 50 % | [27] |
Target coverage | 80 % | 80 % | 80 % | 80 % | 80 % | Authors’ assumption |
Prevalence rates per quintile | 0.25 % | 0.26 % | 0.27 % | 0.29 % | 0.32 % | |
Overall probability of seeking care | 0.08 % | 0.09 % | 0.11 % | 0.13 % | 0.16 % | Authors’ calculations |
Income | ||||||
Average monthly GDP per capita income (current USD) | $641 | $911 | $1177 | $1562 | $3211 | [23] |